Compounded Cerium Nitrate-Silver Sulfadiazine Cream is Safe and Effective for the Treatment of Burn Wounds: A Burn Center's Four-Year Experience. (Record no. 6751)

MARC details
000 -LEADER
fixed length control field 03448nam a22004337a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 211101s20212021 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1559-047X
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 34543402
245 ## - TITLE STATEMENT
Title Compounded Cerium Nitrate-Silver Sulfadiazine Cream is Safe and Effective for the Treatment of Burn Wounds: A Burn Center's Four-Year Experience.
251 ## - Source
Source Journal of Burn Care & Research. 2021 Sep 20
252 ## - Abbreviated Source
Abbreviated source J Burn Care Res. 2021 Sep 20
253 ## - Journal Name
Journal name Journal of burn care & research : official publication of the American Burn Association
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2021
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2022
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
266 ## - Date added to catalog
Date added to catalog 2021-11-01
520 ## - SUMMARY, ETC.
Abstract Wound infections and sepsis are significant causes of morbidity after burn injury and can be alleviated by early excision and grafting. In situations that preclude early surgery, topical agents allow for a safer delay. Cerium nitrate compounded with silver sulfadiazine (Ce-SSD) is a burn cream that provides broad antibacterial activity, forms a temporary barrier, and promotes re-epithelialization. Methemoglobinemia is a rare, but oft-cited, systemic complication of Ce-SSD. In this retrospective review, 157 patients treated with Ce-SSD between July 2014 - July 2018 were identified and the monitoring protocol for methemoglobinemia during Ce-SSD treatment was evaluated. Median age was 59 years (IQR, 47-70.5 years), with total body surface area burn (TBSA) of 8.5% (IQR, 3-27), adjusted Baux score of 76 (IQR, 59-94), and inhalation injury present in 9.9% of patients. Primary endpoints included incidence of symptomatic and asymptomatic methemoglobinemia. Of the 9.6% (n = 15) of patients with methemoglobinemia, 73.3% (n=11) had maximum methemoglobin levels >= 72 hours from time of first application. One patient developed clinically significant methemoglobinemia. Patients with TBSA >= 20% were more likely to develop methemoglobinemia (OR 9.318, 95% CI 2.078 to 65.73, p = 0.0078), however neither Ce-SSD doses nor days of exposure were significant predictors. Ce-SSD application to temporize burn wounds until excision and grafting is safe, effective, and, in asymptomatic patients with TBSA < 20%, can be used without serial blood gas monitoring. Vigilant monitoring for symptoms should be performed in patients with TBSA >= 20%, but routine blood gases are not necessary. Copyright (c) The Author(s) 2021. Published by Oxford University Press on behalf of the American Burn Association. All rights reserved. For permissions, please e-mail: [email protected].
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Health Research Institute
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Burn Research Fellowship
656 ## - INDEX TERM--OCCUPATION
Department Firefighters' Burn and Surgical Research Laboratory
656 ## - INDEX TERM--OCCUPATION
Department MedStar General Surgery Residency
656 ## - INDEX TERM--OCCUPATION
Department Surgery/Burn Services
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Garg, Gaurav
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Johnson, Laura
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Keyloun, John
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors McLawhorn, Melissa M
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Moffatt, Lauren T
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Reese, Adam
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Shupp, Jeffrey W
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Travis, Taryn E
790 ## - Authors
All authors Garg G, Johnson LS, Keyloun JW, McLawhorn MM, Moffatt LT, Reese AD, Shupp JW, Travis TE
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1093/jbcr/irab180">https://dx.doi.org/10.1093/jbcr/irab180</a>
Public note https://dx.doi.org/10.1093/jbcr/irab180
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 11/01/2021   34543402 34543402 11/01/2021 11/01/2021 Journal Article

Powered by Koha